default author photo

Anthony Joshua

The Kinghorn Cancer Centre

370 Victoria Street

Sydnet, NSW 2010

Australia

SCHOLARLY PAPERS

4

DOWNLOADS

198

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

The Metformin Active Surveillance Trial for Low-Risk Prostate Cancer

Number of pages: 24 Posted: 16 Apr 2025
University of Toronto - University Health Network, Princess Margaret Hospital, University of Western Ontario, University of Manitoba, affiliation not provided to SSRN, Nanostics Inc, McGill University - McGill University Health Centre, affiliation not provided to SSRN, University of Montréal - Cancer Prognostics and Health Outcomes Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto - Princess Margaret Cancer Centre, affiliation not provided to SSRN, University of Toronto - University Health Network, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - University Health Network, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and The Kinghorn Cancer Centre
Downloads 80 (816,709)

Abstract:

Loading...

Metformin, Prostate Cancer, Active Surveillance

2.

Pembrolizumab and Denosumab in clear-cell renal-cell carcinoma

Number of pages: 28 Posted: 15 Dec 2025
affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, affiliation not provided to SSRN, The University of Western Australia - Fiona Stanley Hospital, affiliation not provided to SSRN, University of Queensland, Border Medical Oncology, Monash Health, affiliation not provided to SSRN, Flinders University, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Macquarie University, The Kinghorn Cancer Centre, Peter MacCallum Cancer Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Monash University and affiliation not provided to SSRN
Downloads 43 (1,145,425)

Abstract:

Loading...

renal cell carcinoma, Immune checkpoint inhibitors, RANKL inhibition, clinical trial, pembrolizumab, denosumab

3.

Defining Melanoma Quality Indicators: A Modified Delphi Approach

Number of pages: 22 Posted: 23 Aug 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto - Princess Margaret Cancer Centre, affiliation not provided to SSRN, University of Toronto, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Western University, University of Toronto - Sunnybrook Health Sciences Centre, The Kinghorn Cancer Centre, affiliation not provided to SSRN, NHS Foundation Trust - Norfolk and Norwich University Hospital, The University of Sydney, University of Toronto, University of Ottawa, University of Toronto - Sunnybrook Health Sciences Centre, affiliation not provided to SSRN, University of Toronto, affiliation not provided to SSRN and University of Toronto - Sunnybrook Health Sciences Centre
Downloads 38 (1,209,354)

Abstract:

Loading...

Melanoma, quality indicators, outcome measures, modified Delphi approach, cancer system performance

4.

Efficacy of Immune Checkpoint Inhibitors in Advanced Mucosal Melanoma: A Systematic Review and Meta-Analysis

Number of pages: 31 Posted: 27 Jan 2025
The Kinghorn Cancer Centre, Royal North Shore Hospital, The Kinghorn Cancer Centre, The Kinghorn Cancer Centre, University Hospital Zurich, University Hospital Zurich - Department of Dermatology, The Kinghorn Cancer Centre and The Kinghorn Cancer Centre
Downloads 37 (1,222,651)

Abstract:

Loading...

Meta-analysis, mucosal melanoma, Immune checkpoint inhibitor, survival benchmarks